Minerva Surgical, Inc. on February 7, 2023, the board of directors (the “ Board”) of the Company, in connection with and contingent upon the closing of the Private Placement, appointed Dr. Uri Geiger to the Board as a director of the Company, effective as of the closing of the Private Placement. Dr. Geiger is a co-founder and Managing Partner of Accelmed Partners, a private equity investment firm he co-founded in 2009 focused on medical device companies. Prior to founding Accelmed Partners, Dr. Geiger served as the CEO of Exalenz Bioscience Ltd., a medical technology company, from May 2006 until December 2008.

Prior to that, Dr. Geiger co-founded and was the CEO of GalayOr Networks, a developer of optical components from 2001 until 2003. Dr. Geiger was also the founding partner of Dragon Variation Fund in 2000, one of Israel's first hedge funds, which was sold to Migdal in 2007. Dr. Geiger worked on Wall Street during the 1990s, where he gained a broad understanding of and significant experience in capital markets.

Dr. Geiger was formerly an adjunct professor at Tel Aviv University's Recanati School of Business where he lectured on private equity and venture capital and authored the books “Startup Companies and Venture Capital” and “From Concept to Wall Street.” Dr. Geiger served as the chairman of the board of Cogentix Medical from November 2016 until its sale in April 2018. He currently serves on the board of Strata Skin Sciences, Inc. and NeuroPace, Inc., since 2018 and January 2023, respectively, as well as a number of private medical device companies.